![Tai Ching Ho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tai Ching Ho
Geen lopende functies
Profiel
Tai Ching Ho is the founder of two companies.
He founded BeiGene Ltd. in 2010 and served as President from 2010 to 2012.
He also founded Metastagen, Inc. in 2013 and served as Chief Executive Officer from 2013 to 2014.
Dr. Ho held several former jobs, including Vice President-Oncology Development at Johnson & Johnson from 2008 to 2010, Chief Medical Officer & Executive Vice President at Epizyme, Inc. from 2015 to 2017, and Senior Vice President-Oncology Center at GlaxoSmithKline LLC.
He was also Chief Medical Officer at Boston Pharmaceuticals, Inc. from 2018 to 2020 and Independent Director at Aravive, Inc. from 2021 to 2024.
Dr. Ho received his undergraduate degree from The Johns Hopkins University and his doctorate from Yale School of Medicine.
Eerdere bekende functies van Tai Ching Ho
| Bedrijven | Functie | Einde |
|---|---|---|
| ARAVIVE, INC. | Directeur/Bestuurslid | 17-01-2024 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
| EPIZYME, INC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2017 |
Metastagen, Inc.
 Metastagen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | 01-09-2014 |
| BEIGENE LTD | Oprichter | 01-12-2012 |
Opleiding van Tai Ching Ho
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
46
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Metastagen, Inc.
Metastagen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
